An update on LDL apheresis for nephrotic syndrome.

Title

An update on LDL apheresis for nephrotic syndrome.

Creator

Raina Rupesh; Krishnappa Vinod

Publisher

Pediatric nephrology (Berlin, Germany)

Date

2018
2018-09

Description

Low-density lipoprotein (LDL) apheresis has been used increasingly in clinical practice for the treatment of renal diseases with nephrotic syndrome (NS), specifically focal segmental glomerulosclerosis (FSGS). Persistent hyperlipidemia for prolonged periods is nephrotoxic and leads to chronic progressive glomerular and tubulointerstitial injury. Effective management of hyperlipidemia with

Subject

Focal segmental glomerulosclerosis; Hyperlipidemia; Liposorber(R) LA-15 System; Low-density lipoprotein apheresis; Nephrotic syndrome; Podocyte injury

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Citation

Raina Rupesh; Krishnappa Vinod, “An update on LDL apheresis for nephrotic syndrome.,” NEOMED Bibliography Database, accessed September 20, 2021, https://neomed.omeka.net/items/show/3200.

Social Bookmarking